Understanding the similarities and appreciating the differences between drug and medical device clinical trials is important for every trial participant—from the patients to the researchers. Whether the product being investigated is a drug or device, a well-organized, efficient clinical trial can save time and money for each individual and organization involved. Additionally, the faster and more accurately a trial is performed, the faster the new medication or clinical product can be introduced to the market and begins helping the community.
So, while the investigations of drugs and devices have their differences, by design these differences are intended to accomplish the game goal: to safeguard those research participants while bringing safe and effective products to the market as quickly as possible.
Please take time to download IMARC’s “Comparing Drugs & Devices: How are the Clinical Trials Regulated?”